Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS)
CNY 17.19
(-0.86%)
CNY 17.19
(-0.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -81.88 Million | 584.97 Million | 641.93 Million | 1.14 Billion | 76.66 Million | 80.63 Million |
| Net Income | -136.85 Million | 760.27 Million | 758.52 Million | 932 Million | 51.52 Million | 62.31 Million |
| Depreciation & Amortization | 67.28 Million | 60.23 Million | 24.83 Million | 19.67 Million | 22.71 Million | 22.3 Million |
| Deferred income taxes | -27.7 Million | -407.58 Thousand | -51.1 Thousand | -4.46 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -157.1 Million | -180.93 Million | -181.03 Million | 129.17 Million | -4.38 Million | -5.54 Million |
| Other non-cash items | 464.78 Million | -54.6 Million | 39.6 Million | 60.93 Million | 6.8 Million | 1.56 Million |
| Investing Cash Flow | -77.68 Million | -76.02 Million | -519.06 Million | -86.3 Million | -31.55 Million | -24.48 Million |
| Investments in PPE | -81.14 Million | -74.55 Million | -498.06 Million | -74.57 Million | -23.55 Million | -17.48 Million |
| Acquisitions | 1.13 Million | 63.66 Thousand | - | 60.79 Thousand | - | - |
| Investment purchases | -3.45 Million | -51.2 Million | -21 Million | -12 Million | -8 Million | -7 Million |
| Sales/Maturities of investments | 2.31 Million | 49.67 Million | - | -60.79 Thousand | - | - |
| Other Investing Activities | 3.45 Million | 1.04 | -21 Million | 274.71 Thousand | -23.55 Million | -17.48 Million |
| Financing Cash Flow | -234.39 Million | -371.4 Million | 1.62 Billion | -68.5 Million | -65.71 Million | -189.5 Thousand |
| Debt repayment | -3.65 Million | -3.75 Million | - | - | - | - |
| Dividends payments | -230.74 Million | -265.61 Million | -311.52 Million | -65.71 Million | -65.71 Million | -189.5 Thousand |
| Common Stock Repurchased | - | -102.03 Million | - | - | - | - |
| Common Stock Issuance | - | 105.78 Million | 1.95 Billion | - | - | - |
| Other Financing Activities | -3.65 Million | -105.78 Million | -19.3 Million | -2.79 Million | - | - |
| Accounts receivables | 114.77 Million | 12.16 Million | -25.19 Million | -122.29 Million | -5 Million | -7.1 Million |
| Accounts payables | -304.21 Million | 104.49 Million | 16.72 Million | 346.87 Million | 13.4 Million | -5.25 Million |
| Inventory | 31.72 Million | -297.19 Million | -172.51 Million | -90.93 Million | -12.47 Million | 6.57 Million |
| Other working capital | 613.55 Thousand | -407.58 Thousand | -51.1 Thousand | -4.46 Million | -312.57 Thousand | -12.12 Million |
| Cash at beginning of period | 3.14 Billion | 2.93 Billion | 1.2 Billion | 245.87 Million | 265.83 Million | 207.67 Million |
| Cash at end of period | 2.76 Billion | 3.14 Billion | 2.93 Billion | 1.2 Billion | 245.87 Million | 265.83 Million |
| Capital Expenditure | -81.14 Million | -74.55 Million | -498.06 Million | -74.57 Million | -23.55 Million | -17.48 Million |
| Effect of forex changes on cash | 15.77 Million | 74.35 Million | -19.81 Million | -28.35 Million | 648.38 Thousand | 2.2 Million |
| Net cash flow / Change in cash | -378.22 Million | 211.9 Million | 1.73 Billion | 958.63 Million | -19.96 Million | 58.15 Million |
| Free Cash Flow | -163.03 Million | 510.41 Million | 143.87 Million | 1.06 Billion | 53.1 Million | 63.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -39.01 Million | -901.95 Thousand | 26.9 Million | -136.85 Million | -171.49 Million | 3.02 Million |
| Depreciation & Amortization | - | 38.02 Million | - | 67.28 Million | 20.36 Million | -26.06 Million |
| Deferred income taxes | - | - | - | -27.7 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 32.09 Million | - | -157.1 Million | 147.1 Million | -57.62 Million |
| Other non-cash items | 43.03 Million | 23.52 Million | -10.62 Million | 464.78 Million | 255.22 Million | 113.25 Million |
| Investing Cash Flow | -2.34 Million | -5.16 Million | -13.02 Million | -77.68 Million | -35.38 Million | -8.95 Million |
| Investments in PPE | -2.35 Million | -7.33 Million | -13.07 Million | -81.14 Million | -31.62 Million | -15.6 Million |
| Acquisitions | 8853.10 | 2.16 Million | 48.67 Thousand | 1.13 Million | -3.75 Million | 4.32 Million |
| Investment purchases | - | - | - | -3.45 Million | 3.75 Million | -6.64 Million |
| Sales/Maturities of investments | - | - | - | 2.31 Million | 0.10 | 2.31 Million |
| Other Investing Activities | - | 2.16 Million | 48.67 Thousand | 3.45 Million | -3.75 Million | 6.64 Million |
| Financing Cash Flow | -6.23 Million | -16.79 Million | -13.44 Million | -234.39 Million | -1.23 Million | -2.41 Million |
| Debt repayment | - | - | - | -3.65 Million | - | - |
| Dividends payments | - | - | - | -230.74 Million | - | - |
| Common Stock Repurchased | 28.76 Million | -28.76 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -35 Million | -16.79 Million | -13.44 Million | -3.65 Million | 233.15 Million | -2.41 Million |
| Accounts receivables | - | 20.98 Million | - | 114.77 Million | 114.77 Million | -47.79 Million |
| Accounts payables | - | - | - | -304.21 Million | - | - |
| Inventory | - | 11.11 Million | - | 31.72 Million | 31.72 Million | -9.82 Million |
| Other working capital | - | - | - | 613.55 Thousand | 613.55 Thousand | - |
| Cash at beginning of period | 2.76 Billion | 2.76 Billion | 2.76 Billion | 3.14 Billion | 2.75 Billion | 2.74 Billion |
| Cash at end of period | 2.74 Billion | 2.76 Billion | 2.76 Billion | 2.76 Billion | 2.76 Billion | 2.75 Billion |
| Capital Expenditure | -2.35 Million | -7.33 Million | -13.07 Million | -81.14 Million | -31.62 Million | -15.6 Million |
| Effect of forex changes on cash | - | 4.38 Million | 1.21 Million | 15.77 Million | -15.25 Million | -6.83 Million |
| Net cash flow / Change in cash | -21.08 Million | 4.83 Million | -8.98 Million | -378.22 Million | 11.46 Million | 14.37 Million |
| Free Cash Flow | 1.67 Million | 15.28 Million | 3.2 Million | -163.03 Million | 31.74 Million | 16.98 Million |
FRGE
MENA
ENS
002597
603697
NVA